GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemiaAdriano Venditti, Sergio Amadori, Valeria Calafiore et al.|Blood|2019Cited by 215
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular AspectsBruno Fattizzo, Nicola Fracchiolla, Jéssica Rosa et al.|Frontiers in Oncology|2020Cited by 81